Racura Oncology Ltd (ASX:RAC)
Australia · Delayed Price · Currency is AUD 2.010
-0.020 (-0.99%)
Aug 7, 2026, 3:59 PM AEST
Racura Oncology Market Cap
Racura Oncology has a market cap or net worth of 390.14 million as of August 7, 2026. Its market cap has increased by 89.49% in one year.
Market Cap
390.14M
Enterprise Value
369.20M
Revenue
3.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.01
ChartMarket Cap Chart
Since July 13, 2016, Racura Oncology's market cap has increased from 12.64M to 390.14M, an increase of 2,987.25%. That is a compound annual growth rate of 40.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 390.14M | -20.97% |
| Dec 31, 2025 | 493.64M | 110.49% |
| Dec 31, 2024 | 234.51M | 70.76% |
| Dec 29, 2023 | 137.34M | -57.61% |
| Dec 30, 2022 | 324.00M | -43.55% |
| Dec 31, 2021 | 574.00M | 153.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clarity Pharmaceuticals | 1.00B |
| Clinuvel Pharmaceuticals | 476.04M |
| Tetratherix | 408.52M |
| Starpharma Holdings | 332.71M |
| BLS Pharmaceuticals | 209.28M |
| Orthocell | 198.75M |
| Nyrada | 182.70M |
| Dimerix | 165.11M |